Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer

1. He J, Chen WQ, Li ZS, Li N, Ren JS, Tian JH, et al. [China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022; 44: 491-522. doi: 10.3760/cma.j.cn112152-20220517-00348 He J Chen WQ Li ZS Li N Ren JS Tian JH [China guideline for the screening early detection and early treatment of esophageal cancer (2022, Beijing)]. [Chinese] . Zhonghua Zhong Liu Za Zhi 2022 ; 44 : 491 - 522 . doi: 10.3760/cma.j.cn112152-20220517-00348 Open DOISearch in Google Scholar

2. Li S, Chen H, Man J, Zhang T, Yin X, He Q, et al. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med 2021; 10: 1889-99. doi: 10.1002/cam4.3775 Li S Chen H Man J Zhang T Yin X He Q Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years . Cancer Med 2021 ; 10 : 1889 - 99 . doi: 10.1002/cam4.3775 Open DOISearch in Google Scholar

3. Early Diagnosis and treatment group of the Chinese Medical Association Oncology Branch. [Chinese expert consensus on early diagnosis and treatment of esophageal cancer]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022; 44: 1066-75. doi: 10.3760/cma.j.cn112152-20220220-00114 Early Diagnosis and treatment group of the Chinese Medical Association Oncology Branch . [Chinese expert consensus on early diagnosis and treatment of esophageal cancer]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022 ; 44 : 1066 - 75 . doi: 10.3760/cma.j.cn112152-20220220-00114 Open DOISearch in Google Scholar

4. National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018. Chin J Cancer Res 2019; 31: 223-58. doi: 10.21147/j.issn.1000-9604.2019.02.01 National Health Commission of the People’s Republic of China . Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 . Chin J Cancer Res 2019 ; 31 : 223 - 58 . doi: 10.21147/j.issn.1000-9604.2019.02.01 Open DOISearch in Google Scholar

5. Shi Z, Zhu X, Ruan C, Wei G, Li J, Qiu H, et al. Evaluation of concurrent chemoradiotherapy for survival outcomes in patients with synchronous oligometastatic esophageal squamous cell carcinoma. JAMA Netw Open 2022; 5: e2244619. doi: 10.1001/jamanetworkopen.2022.44619 Shi Z Zhu X Ruan C Wei G Li J Qiu H Evaluation of concurrent chemoradiotherapy for survival outcomes in patients with synchronous oligometastatic esophageal squamous cell carcinoma . JAMA Netw Open 2022 ; 5 : e2244619 . doi: 10.1001/jamanetworkopen.2022.44619 Open DOISearch in Google Scholar

6. Luo D, Zhong Q, Yue H, Wang J, Liang Q, Liu W, et al. The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma. Cancer Biol Ther 2024; 25: 2371632. doi: 10.1080/15384047.2024.2371632 Luo D Zhong Q Yue H Wang J Liang Q Liu W The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma . Cancer Biol Ther 2024 ; 25 : 2371632 . doi: 10.1080/15384047.2024.2371632 Open DOISearch in Google Scholar

7. Cinicola J, Mamidanna S, Yegya-Raman N, Spencer K, Deek MP, Jabbour SK. A review of advances in radiotherapy in the setting of esophageal cancers. Surg Oncol Clin N Am 2023; 32: 433-59. doi: 10.1016/j.soc.2023.03.004 Cinicola J Mamidanna S Yegya-Raman N Spencer K Deek MP Jabbour SK. A review of advances in radiotherapy in the setting of esophageal cancers . Surg Oncol Clin N Am 2023 ; 32 : 433 - 59 . doi: 10.1016/j.soc.2023.03.004 Open DOISearch in Google Scholar

8. Wang X, Wang P, Huang X, Han Y, Zhang P. Biomarkers for immunotherapy in esophageal cancer. Front Immunol 2023; 14: 1117523. doi: 10.3389/fimmu.2023.1117523 Wang X Wang P Huang X Han Y Zhang P. Biomarkers for immunotherapy in esophageal cancer . Front Immunol 2023 ; 14 : 1117523 . doi: 10.3389/fimmu.2023.1117523 Open DOISearch in Google Scholar

9. Suzuki R, Lin SH, Wei X, Allen PK, Welsh JW, Byers LA, et al. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Radiother Oncol 2018; 126: 499-505. doi: 10.1016/j.radonc.2017.12.030 Suzuki R Lin SH Wei X Allen PK Welsh JW Byers LA Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer . Radiother Oncol 2018 ; 126 : 499 - 505 . doi: 10.1016/j.radonc.2017.12.030 Open DOISearch in Google Scholar

10. Cox S, Hurt C, Grenader T, Mukherjee S, Bridgewater J, Crosby T. The prognostic value of derived neutrophil to lymphocyte ratio in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 2017; 125: 154-9. doi: 10.1016/j.radonc.2017.08.023 Cox S Hurt C Grenader T Mukherjee S Bridgewater J Crosby T. The prognostic value of derived neutrophil to lymphocyte ratio in esophageal cancer treated with definitive chemoradiotherapy . Radiother Oncol 2017 ; 125 : 154 - 9 . doi: 10.1016/j.radonc.2017.08.023 Open DOISearch in Google Scholar

11. Huang D, Zhu XZ, Sheng WQ. [2019 updates of the WHO classification of the digestive system tumors, part: epithelial neoplasms in gastrointestinal tract]. [Chinese]. Zhonghua Bing Li Xue Za Zhi 2020; 49: 209-13. doi: 10.3760/cma.j.issn.0529-5807.2020.03.001 Huang D Zhu XZ Sheng WQ. [2019 updates of the WHO classification of the digestive system tumors part: epithelial neoplasms in gastrointestinal tract] . [Chinese]. Zhonghua Bing Li Xue Za Zhi 2020 ; 49 : 209 - 13 . doi: 10.3760/cma.j.issn.0529-5807.2020.03.001 Open DOISearch in Google Scholar

12. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-4. doi: 10.1001/jama.2013.281053 World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects . JAMA 2013 ; 310 : 2191 - 4 . doi: 10.1001/jama.2013.281053 Open DOISearch in Google Scholar

13. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026 Eisenhauer EA Therasse P Bogaerts J Schwartz LH Sargent D Ford R New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) . Eur J Cancer 2009 ; 45 : 228 - 47 . doi: 10.1016/j.ejca.2008.10.026 Open DOISearch in Google Scholar

14. Wang H, Lan L, Chen J, Xiao L, Han F. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients. Lupus Sci Med 2022; 9: e000717. doi:10.1136/lupus-2022-000717 Wang H Lan L Chen J Xiao L Han F. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients . Lupus Sci Med 2022 ; 9 : e000717 . doi: 10.1136/lupus-2022-000717 Open DOISearch in Google Scholar

15. Khan J, Lieberman JA, Lockwood CM. Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs. Clin Chem Lab Med 2017; 55: 608-21. doi: 10.1515/cclm-2016-0471 Khan J Lieberman JA Lockwood CM. Variability in variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs . Clin Chem Lab Med 2017 ; 55 : 608 - 21 . doi: 10.1515/cclm-2016-0471 Open DOISearch in Google Scholar

16. Zegels G, Van Raemdonck GA, Tjalma WA, Van Ostade XW. Use of cervicov-aginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci 2010; 8: 63. doi: 10.1186/1477-5956-8-63 Zegels G Van Raemdonck GA Tjalma WA Van Ostade XW. Use of cervicov-aginal fluid for the identification of biomarkers for pathologies of the female genital tract . Proteome Sci 2010 ; 8 : 63 . doi: 10.1186/1477-5956-8-63 Open DOISearch in Google Scholar

17. Pleil JD, Wallace MAG, Stiegel MA, Funk WE. Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates. J Toxicol Environ Health B Crit Rev 2018; 21: 161-80. doi: 10.1080/10937404.2018.1490128 Pleil JD Wallace MAG Stiegel MA Funk WE. Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates . J Toxicol Environ Health B Crit Rev 2018 ; 21 : 161 - 80 . doi: 10.1080/10937404.2018.1490128 Open DOISearch in Google Scholar

18. Zhang J, Dasgupta A, Ayala R, Bonapace C, Kassim S, Faustino PJ. Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations. Bioanalysis 2024; 16: 771-6. doi: 10.1080/17576180.2024.2348939 Zhang J Dasgupta A Ayala R Bonapace C Kassim S Faustino PJ. Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations . Bioanalysis 2024 ; 16 : 771 - 6 . doi: 10.1080/17576180.2024.2348939 Open DOISearch in Google Scholar

19. Shao N, Cai Q. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol 2015; 17: 772-8. doi: 10.1007/s12094-015-1289-8 Shao N Cai Q. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer . Clin Transl Oncol 2015 ; 17 : 772 - 8 . doi: 10.1007/s12094-015-1289-8 Open DOISearch in Google Scholar

20. Shao B, Li H, Liu X, Song G, Jiang H, Yan Y, et al. The prognostic value of neu-trophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study. Ann Transl Med 2023; 11: 45. doi: 10.21037/atm-22-5612 Shao B Li H Liu X Song G Jiang H Yan Y The prognostic value of neu-trophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study . Ann Transl Med 2023 ; 11 : 45 . doi: 10.21037/atm-22-5612 Open DOISearch in Google Scholar